GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gujarat Terce Laboratories Ltd (BOM:524314) » Definitions » Market Cap

Gujarat Terce Laboratories (BOM:524314) Market Cap : ₹415.2 Mil (As of May. 25, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Gujarat Terce Laboratories Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Gujarat Terce Laboratories's share price for the quarter that ended in Dec. 2023 was ₹28.49. Gujarat Terce Laboratories's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 7.4 Mil. Therefore, Gujarat Terce Laboratories's market cap for the quarter that ended in Dec. 2023 was ₹211.4 Mil.

Gujarat Terce Laboratories's quarterly market cap declined from Jun. 2023 (₹218.5 Mil) to Sep. 2023 (₹185.6 Mil) but then increased from Sep. 2023 (₹185.6 Mil) to Dec. 2023 (₹211.4 Mil).

Gujarat Terce Laboratories's annual market cap increased from Mar. 2021 (₹51.6 Mil) to Mar. 2022 (₹194.0 Mil) but then declined from Mar. 2022 (₹194.0 Mil) to Mar. 2023 (₹123.6 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Gujarat Terce Laboratories's Enterprise Value for Today is ₹458.8 Mil.


Gujarat Terce Laboratories Market Cap Historical Data

The historical data trend for Gujarat Terce Laboratories's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gujarat Terce Laboratories Market Cap Chart

Gujarat Terce Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 67.52 46.97 51.65 194.04 123.62

Gujarat Terce Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 135.42 123.62 218.53 185.58 211.40

Competitive Comparison of Gujarat Terce Laboratories's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Gujarat Terce Laboratories's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gujarat Terce Laboratories's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gujarat Terce Laboratories's Market Cap distribution charts can be found below:

* The bar in red indicates where Gujarat Terce Laboratories's Market Cap falls into.



Gujarat Terce Laboratories Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Gujarat Terce Laboratories's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as

Market Cap (A: Mar. 2023 )=Share Price (A: Mar. 2023 )*Shares Outstanding (EOP) (A: Mar. 2023 )
=₹16.66*7.4203
=₹123.6

Gujarat Terce Laboratories's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=₹28.49*7.4203
=₹211.4

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gujarat Terce Laboratories  (BOM:524314) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Gujarat Terce Laboratories Market Cap Related Terms

Thank you for viewing the detailed overview of Gujarat Terce Laboratories's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Gujarat Terce Laboratories (BOM:524314) Business Description

Traded in Other Exchanges
N/A
Address
Near Shivalik High-Street,, D/801 & 802,The First,, Behind Keshavbaug Party Plot,, Vastrapur,, Ahmedabad, GJ, IND, 380015
Gujarat Terce Laboratories Ltd is an India company having business in the medical and pharmaceutical preparations. It is engaged in the manufacturing of tablets, capsules, and syrup and injection. It offers branded as well as generic formulations covering different therapeutic areas such as antibiotics, respiratory, nutraceuticals, gastrointestinal, anti-fungal, and many more. Some of the main brands are Acolate, Tynol, DFS, Resplash , Aziter and others.

Gujarat Terce Laboratories (BOM:524314) Headlines

No Headlines